Trade

with

Geron Corp
(NASDAQ: GERN)
AdChoices
2.21
+0.06
+2.79%
After Hours :
2.21
+0.00
+0.01%

Open

2.16

Previous Close

2.15

Volume (Avg)

2.82M (2.06M)

Day's Range

2.15-2.28

52Wk Range

1.39-7.79

Market Cap.

346.71M

Dividend Rate ( Yield )

-

Beta

1.90

Shares Outstanding

156.88M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Biotechnology
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 1.28M

    • Net Income

    • -38.38M

    • Market Cap.

    • 346.71M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -2,842.67

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.90

    • Forward P/E

    • -11.20

    • Price/Sales

    • 243.90

    • Price/Book Value

    • 2.33

    • Price/Cash flow

    • -11.07

      • EBITDA

      • -38.00M

      • Return on Capital %

      • -31.16

      • Return on Equity %

      • -32.59

      • Return on Assets %

      • -31.16

      • Book Value/Share

      • 0.92

      • Shares Outstanding

      • 156.88M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • -

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 204.50

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • -14.47

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 100.00

            • 82.75

            • Pre-Tax Margin

            • -2,842.67

            • 39.38

            • Net Profit Margin

            • -2,842.67

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • 100.00

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -3,342.00

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.76

              • Current Ratio

              • 29.98

              • 2.92

              • Quick Ratio

              • 29.77

              • 2.35

              • Interest Coverage

              • -549.94

              • 38.02

              • Leverage Ratio

              • 1.03

              • 2.21

              • Book Value/Share

              • 0.92

              • 4.79

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -8.67

                • 243.90

                • P/E Ratio 5-Year High

                • -29.56

                • 634.30

                • P/E Ratio 5-Year Low

                • -3.45

                • 124.82

                • Price/Sales Ratio

                • 243.90

                • 9.29

                • Price/Book Value

                • 2.34

                • 8.39

                • Price/Cash Flow Ratio

                • -11.07

                • 49.75

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -32.59

                        (-54.30)

                      • 37.63

                        (27.20)

                      • Return on Assets %

                        (5-Year Average)

                      • -31.16

                        (-48.30)

                      • 17.22

                        (13.81)

                      • Return on Capital %

                        (5-Year Average)

                      • -32.53

                        (-54.40)

                      • 21.78

                        (17.31)

                      • Income/Employee

                      • -

                      • 117.08k

                      • Inventory Turnover

                      • -

                      • 1.48

                      • Asset Turnover

                      • 0.01

                      • 0.55

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -38.96M
                      Operating Margin
                      -3,036.48
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -11.07
                      Ownership

                      Institutional Ownership

                      51.25%

                      Top 10 Institutions

                      40.16%

                      Mutual Fund Ownership

                      33.06%

                      Float

                      86.92%

                      5% / Insider Ownership

                      3.16%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Fidelity® Select Biotechnology Portfolio

                      •  

                        15,693,826

                      • 0.00

                      • 10.00

                      • SPDR® S&P Biotech ETF

                      •  

                        7,197,742

                      • 0.00

                      • 4.95

                      • British & American Investment Trust PLC

                      •  

                        3,480,242

                      • 0.11

                      • 2.82

                      • Fidelity® Puritan® Fund

                      •  

                        3,141,000

                      • 0.00

                      • 2.00

                      • Fidelity Advisor® Biotechnology Fund

                      •  

                        2,782,517

                      • 0.00

                      • 1.77

                      • Vanguard Total Stock Mkt Idx

                      •  

                        2,577,302

                      • 0.00

                      • 1.64

                      • iShares Russell 2000 (AU)

                      •  

                        2,431,453

                      • -0.90

                      • 1.67

                      • iShares Nasdaq Biotechnology

                      •  

                        2,044,014

                      • -1.85

                      • 1.41

                      • Vanguard Extended Market Index Fund

                      •  

                        1,525,852

                      • 0.39

                      • 0.97

                      • Fidelity Advisor® Growth Opportunities

                      •  

                        1,222,800

                      • 0.00

                      • 0.78

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Fidelity Management and Research Company

                      •  

                        23,540,743

                      • +1.37%

                      • 15.88

                      • State Street Corp

                      •  

                        7,577,092

                      • -39.68%

                      • 5.11

                      • BlackRock Fund Advisors

                      •  

                        5,789,150

                      • -7.44%

                      • 3.91

                      • Camber Capital Management LLC

                      •  

                        5,000,000

                      • +6.38%

                      • 3.37

                      • Vanguard Group, Inc.

                      •  

                        4,773,645

                      • +2.32%

                      • 3.22

                      • Arnhold & S. Bleichroeder Advisers, LLC

                      •  

                        3,548,124

                      • +16.17%

                      • 2.39

                      • British & American Investment Trust PLC

                      •  

                        3,480,242

                      • +0.11%

                      • 2.82

                      • Redmile Group, LLC

                      •  

                        2,051,312

                      • -3.13%

                      • 1.38

                      • Northern Trust Investments, N.A.

                      •  

                        1,743,202

                      • -9.93%

                      • 1.18

                      • Adage Capital Partners Gp LLC

                      •  

                        1,335,000

                      • -24.79%

                      • 0.90

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Biotechnology

                      Type

                      Slow Growth

                      Style

                      Small Core

                      Geron Corp was incorporated in the State of Delaware on November 28, 1990. It is a clinical stage biopharmaceutical company developing a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The Company operates in t...morehe segment of the discovery and development of therapeutic products for oncology. It owns worldwide commercial rights with U.S. patent coverage extending through 2025 for imetelstat. Its patent rights relating to telomerase cover the cloned genes that encode the RNA component and the catalytic protein component of human telomerase, cells that are immortalized by expression of recombinant hTERT, and cancer diagnostics based on detecting the expression of telomerase in cancer cells. The Company is subject to various and often changing federal, state, local and internationa...morel laws, rules, regulations, guidelines and recommendations relating to safe working conditions and manufacturing practices.lessless

                      Key People

                      Dr. John A. Scarlett,M.D.

                      CEO/Director/President

                      Dr. Hoyoung Huh,M.D.,PhD

                      Chairman of the Board/Director

                      Ms. Olivia K. Bloom

                      CFO/Chief Accounting Officer/Executive VP, Divisional/Treasurer

                      Melissa A. Kelly Behrs

                      Executive VP, Divisional

                      Craig C. Parker

                      Executive VP, Divisional

                      • Geron Corp

                      • 149 Commonwealth Drive

                      • Menlo Park, CA 94025

                      • USA.Map

                      • Phone: +1 650 473-7700

                      • Fax: +1 650 473-7750

                      • geron.com

                      Incorporated

                      1990

                      Employees

                      46

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: